SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of twenty-five major cancers in 1990. Int J Cancer 1999;80: 82741
  • 2
    Pisani P, Parkin DM, Bray F, et al. Estimates of the worldwide mortality from twenty-five major cancers in 1990. Int J Cancer 1999;83: 870873
  • 3
    Tulinius H, Storm HH, Pukkala E, et al. Cancer in the Nordic countries, 1981–86: a joint publication of the five Nordic Cancer Registries. APMIS 1992;31: 1194
  • 4
    National Cancer Institute of Canada. Canadian cancer statistics 1995. Toronto, Canada, 1995.
  • 5
    Benjamin B. Demographic analysis. London: George Allen and Unwin, Ltd., 1968
  • 6
    Ries LA, Kosary CL, Hankey BF, et al., eds. SEER cancer statistics review, 1973–1994, National Cancer Institute. NIH Pub. No. 97-2789. Bethesda, MD, 1997.
  • 7
    Berrino F, Sant M, Verdecchia A, et al. Survival of cancer patients in Europe: the EUROCARE study. IARC Scientific Publications No 132. Lyon: IARC, 1995
  • 8
    National Cancer Centre. Foundation for Promotion of Cancer Research: Figures on cancer in Japan, Tokyo, 1991
  • 9
    Cancer Registry. Epidemiology of cancer in South Australia. Adelaide, 1994.
  • 10
    Wiebelt H, Hakulinen TJ. Do women survive cancer more frequently than men? J Natl Cancer Inst 1991;83: 579580
  • 11
    Murray CJL, Lopez AD. The global burden of disease. Boston: Harvard University Press, 1996.
  • 12
    Sankaranarayanan R, Black RJ, Parkin DM. Cancer survival in developing countries. IARC Scientific Publication no. 145. Lyon: IARC, 1998.
  • 13
    Adami HO, Gunnarson T., Sparén P, Eklund G. The prevalence of cancer in Sweden. Acta Oncologica 1989;4: 46370.
  • 14
    Thomson H, Rahu M, Aareleid T, et al. Cancer in Estonia 1968–1992: incidence, mortality, prevalence, survival. Tallinn, 1996.
  • 15
    The Cancer Registry of Norway. Cancer in Norway 1995. Oslo, 1998.
  • 16
    Micheli A, Francisci S, Krogh V, et al. 1999. Cancer prevalence in Italian cancer registry areas: the ITAPREVAL study. ITAPREVAL Working Group. Tumori 1999;85: 30969.
  • 17
    Hewitt M, Breen N, Devesa S. Cancer prevalence and survivorship issues: analyses of the 1992 National Health Interview Survey. J Natl Cancer Inst 1999;91: 14806.
  • 18
    Byrne J, Kessler LG, Devesa SS. The prevalence of cancer among adults in the United States: 1987. Cancer 1992;69: 21549.
  • 19
    Schrijvers CT, Stronks K, van de Mheen DH, et al. 1994. Validation of cancer prevalence data from a postal survey by comparison with cancer registry records. Am J Epidemiol 1994;139: 40814.
  • 20
    Verdecchia A, Capocaccia R, Egidi V, et al. A method for the estimation of chronic disease morbidity and trends from mortality data. Statistics Med 1989;8: 201216.
  • 21
    Capocaccia R. 1990. Verdecchia A, Micheli A, et al. Breast cancer incidence and prevalence estimated from survival and mortality. Cancer Causes Control 1990;1: 239.
  • 22
    Merrill RM, Capocaccia R, Feuer EJ, et al. Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology and End Results (SEER) program. Int J Epidemiol 2000;29: 197207.
  • 23
    Coldman AJ, McBride ML, Braun T. Calculating the prevalence of cancer. Statistics Med 1992;11: 157989.
  • 24
    Colonna M, Hedelin G, Estève J, et al. National cancer prevalence estimation in France. Int J Cancer 2000; 87: 3014.
  • 25
    Desai MM, Bruce ML, Desai RA, et al. 2001. Validity of self-reported cancer history: a comparison of health interview data and cancer registry records. Am J Epidemiol 2001;153: 299306.
  • 26
    Colonna M, Grosclaude P, Launoy G, et al. Estimation of colorectal cancer prevalence in France. Eur J Cancer 2001;37: 936.